Jazz Pharmaceuticals (JAZZ)
Create an AlertJazz Pharmaceuticals Liabilities:
847.79M for March 31, 2013Jazz Pharmaceuticals Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 847.79M |
| Dec. 31, 2012 | 845.20M |
| Sept. 30, 2012 | 840.61M |
| June 30, 2012 | 866.48M |
| March 31, 2012 | 113.53M |
| Dec. 31, 2011 | 60.78M |
| Sept. 30, 2011 | 66.48M |
| June 30, 2011 | 91.81M |
| March 31, 2011 | 94.10M |
| Dec. 31, 2010 | 105.18M |
| Sept. 30, 2010 | 108.80M |
| June 30, 2010 | 113.56M |
| March 31, 2010 | 175.70M |
| Dec. 31, 2009 | 180.23M |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
JAZZ Liabilities Benchmarks
| Companies | |
|---|---|
| Santarus | 83.08M |
| Cubist Pharmaceuticals | 890.69M |
| Biogen Idec | 2.826B |
JAZZ Liabilities Rankings
| Overall |
62nd percentile 6302 of 16782 |
| Sector |
40th percentile 837 of 1410 in Healthcare |
| Industry |
28th percentile 326 of 454 in Biotechnology |
JAZZ Liabilities Range, Past 5 Years
| Minimum | 60.78M | Dec 2011 |
| Maximum | 866.49M | Jun 2012 |
| Average | 287.26M |
